Cargando…
Clinical information and management status of de novo stage IV breast cancer patients: a Chinese multicenter investigation (CSBrS-002)
BACKGROUND: Although de novo stage IV breast cancer is so far incurable, it has entered an era of individualized treatment and chronic disease management. Based on systemic treatment, whether the surgical resection of primary or metastatic foci of de novo stage IV breast cancer can bring survival be...
Autores principales: | Zheng, Ang, Guo, Bao-Liang, Zhang, Jian-Guo, Jin, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280017/ https://www.ncbi.nlm.nih.gov/pubmed/34101635 http://dx.doi.org/10.1097/CM9.0000000000001415 |
Ejemplares similares
-
Clinical practice guidelines for ductal carcinoma in situ: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Zheng, Ang, et al.
Publicado: (2021) -
Clinical practice guideline for breast fibroadenoma: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021
por: Peng, Yuan, et al.
Publicado: (2021) -
Clinical practice guidelines for intraductal papilloma: Chinese Society of breast surgery (CSBrS) practice guidelines 2021
por: Wu, Di, et al.
Publicado: (2021) -
A multi-center investigation of breast-conserving surgery based on data from the Chinese Society of Breast Surgery (CSBrS-005)
por: Yu, Li-Xiang, et al.
Publicado: (2020) -
Clinical practice guidelines for sentinel lymph node biopsy in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Ye, Jing-Ming, et al.
Publicado: (2021)